Differential regulation of gene expression and insulin-induced activation of phosphodiesterase 3B in adipocytes of lean insulin-resistant IRS-1 (-/-) mice - PubMed (original) (raw)

Comparative Study

Differential regulation of gene expression and insulin-induced activation of phosphodiesterase 3B in adipocytes of lean insulin-resistant IRS-1 (-/-) mice

Masaaki Hasegawa et al. Diabetes Res Clin Pract. 2002 Nov.

Abstract

Phosphodiesterase (PDE) 3B, a major isoform of PDE in adipocytes, mediates the antilipolytic action of insulin. PDE3B gene expression is generally reduced in adipocytes of either monogenic or polygenic rodent models of obese, insulin-resistance. An increased fat cell size, a common feature of obesity, could account for this reduction. Insulin receptor substrate-1 (IRS-1) (-/-) mice are lean with a reduced fat cell size and have insulin resistance due to a primary defect of insulin signaling. To determine whether the regulation of PDE3B gene expression is correlated with fat cell size, we examined this gene expression in adipose tissues of IRS-1 (-/-) mice. In IRS-1 (-/-) mice, PDE3B mRNA and protein levels were increased 1.24- and 1.35-fold those in C57BL/6J control mice, respectively. Independently, the fold induction of PDE activity by insulin (insulin-induced/basal) was 1.7-fold in control mice, but was reduced to 1.35-fold in IRS-1 (-/-) mice. Thus, PDE3B gene expression may be inversely correlated with a fat cell size, whereas insulin-induced PDE3B activation is mediated through IRS-1.

PubMed Disclaimer

Similar articles

• Adipocyte-specific reduction of phosphodiesterase 3B gene expression and its restoration by JTT-501 in the obese, diabetic KKAy mouse.
  Tang Y, Osawa H, Onuma H, Hasegawa M, Nishimiya T, Ochi M, Makino H. Tang Y, et al. Eur J Endocrinol. 2001 Jul;145(1):93-9. doi: 10.1530/eje.0.1450093. Eur J Endocrinol. 2001. PMID: 11415857
• Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice.
  Tang Y, Osawa H, Onuma H, Nishimiya T, Ochi M, Makino H. Tang Y, et al. Diabetes. 1999 Sep;48(9):1830-5. doi: 10.2337/diabetes.48.9.1830. Diabetes. 1999. PMID: 10480615
• Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse.
  Tang Y, Osawa H, Onuma H, Nishimiya T, Ochi M, Sugita A, Makino H. Tang Y, et al. Diabetes Res Clin Pract. 2001 Dec;54(3):145-55. doi: 10.1016/s0168-8227(01)00271-6. Diabetes Res Clin Pract. 2001. PMID: 11689269
• Reduction of phosphodiesterase 3B gene expression in peroxisome proliferator-activated receptor gamma (+/-) mice independent of adipocyte size.
  Ogura T, Osawa H, Tang Y, Onuma H, Ochi M, Nishimiya T, Kubota N, Terauchi Y, Kadowaki T, Makino H. Ogura T, et al. FEBS Lett. 2003 May 8;542(1-3):65-8. doi: 10.1016/s0014-5793(03)00339-9. FEBS Lett. 2003. PMID: 12729899
• Methods to study phosphorylation and activation of the hormone-sensitive adipocyte phosphodiesterase type 3B in rat adipocytes.
  Degerman E, Resjö S, Landström TR, Manganiello V. Degerman E, et al. Methods Mol Biol. 2001;155:167-80. doi: 10.1385/1-59259-231-7:167. Methods Mol Biol. 2001. PMID: 11293069 Review. No abstract available.

Cited by

• Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice.
  Choi YH, Park S, Hockman S, Zmuda-Trzebiatowska E, Svennelid F, Haluzik M, Gavrilova O, Ahmad F, Pepin L, Napolitano M, Taira M, Sundler F, Stenson Holst L, Degerman E, Manganiello VC. Choi YH, et al. J Clin Invest. 2006 Dec;116(12):3240-51. doi: 10.1172/JCI24867. J Clin Invest. 2006. PMID: 17143332 Free PMC article.
• Sirt1 inhibits akt2-mediated porcine adipogenesis potentially by direct protein-protein interaction.
  Pang W, Wang Y, Wei N, Xu R, Xiong Y, Wang P, Shen Q, Yang G. Pang W, et al. PLoS One. 2013 Aug 12;8(8):e71576. doi: 10.1371/journal.pone.0071576. eCollection 2013. PLoS One. 2013. PMID: 23951196 Free PMC article.
• Role of Phosphodiesterase in the Biology and Pathology of Diabetes.
  Kilanowska A, Ziółkowska A. Kilanowska A, et al. Int J Mol Sci. 2020 Nov 3;21(21):8244. doi: 10.3390/ijms21218244. Int J Mol Sci. 2020. PMID: 33153226 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • GlyGen glycoinformatics resource